Send to

Choose Destination
J Breath Res. 2018 Apr 4;12(3):034002. doi: 10.1088/1752-7163/aab108.

Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications.

Author information

Department of Professional Sciences, Middle Tennessee State University, Murfreesboro, Tennessee, United States of America.


Not unlike many cancer types, acute myeloid leukemia (AML) exhibits many metabolic changes and reprogramming, causing changes in lipid metabolism. Some of the distinct molecular abnormalities associated with AML also modify the metabolic changes. Both processes result in changes in the production of endogenous volatile organic compounds (VOCs). The increasing availability of highly sensitive methods for detecting trace chemicals provides the opportunity to investigate the role of patient-specific VOC finger-prints as biomarkers for detecting early relapse or minimal residual disease in AML. Since VOC production is reliant on metabolic activities, when combined with currently available methods, VOC analysis may identify within a group of patients with flow cytometric or molecular evidence of residual disease those most at risk for disease relapse.


Supplemental Content

Full text links

Icon for IOP Publishing Ltd.
Loading ...
Support Center